UBS Maintains Buy on Colgate-Palmolive, Raises Price Target to $100

Benzinga Newsdesk www.benzinga.com Positive 83.6%

Neg 0% Neu 0% Pos 83.6%

UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price target from $98 to $100.

Comments

No comments yet. Be the first!